Breaking News Instant updates and real-time market news.

GNFT

Genfit

$20.19

-0.02 (-0.10%)

, GMDA

Gamida Cell

$7.21

-0.23 (-3.09%)

19:33
06/24/19
06/24
19:33
06/24/19
19:33

Fly Intel: After Hours Movers

HIGHER: Genfit (GNFT), up 3.2% after Terns announced a licensing and collaboration agreement with the company. LOWER: Gamida Cell (GMDA), down 9.9% after filing to sell $30M of ordinary shares.

GNFT

Genfit

$20.19

-0.02 (-0.10%)

GMDA

Gamida Cell

$7.21

-0.23 (-3.09%)

  • 27

    Jun

GNFT Genfit
$20.19

-0.02 (-0.10%)

04/22/19
HCWC
04/22/19
NO CHANGE
Target $72
HCWC
Buy
Genfit price target lowered to $72 from EUR 105 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce lowered his price target for Genfit to $72 from EUR 105 citing the impact of the 24.5% share dilution from the company's recent global offering. The new target, however, still represents about 188% upside from current levels and an implied market capitalization of $2.8B, Arce tells investors in a research note. With Genfit's Nasdaq listing complete, investor focus sharpens on nonalcoholic steatohepatitis and primary biliary cholangitis, adds the analyst. He keeps a Buy rating on the stock.
04/24/19
LEER
04/24/19
INITIATION
Target $58
LEER
Outperform
Genfit initiated with an Outperform at SVB Leerink
SVB Leerink analyst Pasha Sarraf started Genfit with an Outperform rating and $58 price target. The analyst's core thesis in obesity-induced metabolic liver diseases, including nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, is the utility of combining therapies that provide metabolic, and anti-inflammatory/fibrotic benefits on a background of practical weight loss therapies. Genfit's elafibranor may become one of the first products entering the market that fits this thesis with reproducibly meaningful lipid and triglyceride lowering benefits, insulin sensitization and reduction of glycated hemoglobin, and impact on inflammatory hepatic pathology, Sarraf tells investors in a research note.
05/14/19
HCWC
05/14/19
NO CHANGE
HCWC
H.C. Wainwright affirms Buy on Genfit after positive recommendation from DSMB
H.C. Wainwright analyst Ed Arce affirmed a Buy rating and $72 price target on Genfit after the company announced that the the Data Safety Monitoring Board, or DSMB, of the Phase 3 RESOLVE-IT trial of elafibranor for the treatment of NASH, or nonalcoholic steatohepatitis, had "rendered a positive recommendation for the trial's continuation without any changes. This 36-month safety review is the sixth planned review by the DSMB, and revealed no safety issues with elafibranor." The analyst estimates elafibranor's probability of success at 75% for NASH and 60% for PBC, and utilize a 11.5% discount rate, which he believes is "appropriate for a small-cap development stage biotech."
06/11/19
PIPR
06/11/19
NO CHANGE
Target $8
PIPR
Overweight
Piper cuts CymaBay price target to $8 on 'worst case' results for NASH trial
Piper Jaffray analyst Tyler Van Buren said he did not anticipate that placebo would perform better than seladelpar in CymaBay Therapeutics' (CBAY) Phase 2b study of the drug for the treatment of nonalcoholic steatohepatitis. Calling the NASH trial results a "worst case scenario," Van Buren sees significant risk to the final 52-week data read-out and removed all expectations in NASH from his model. He said the data make seladelpar seem similar to Genfit's (GNFT) elafibranor, though seladelpar has not yet shown improvements in good cholesterol, glucose homeostatis, or insulin resistance. While Van Buren cut his price target on CymaBay shares to $8 from $30 based on the trial results, he keeps an Overweight rating on the shares given the sharp pullback this morning and the support he sees from the company's remaining cash and residual opportunity.
GMDA Gamida Cell
$7.21

-0.23 (-3.09%)

11/21/18
OPCO
11/21/18
INITIATION
Target $15
OPCO
Outperform
Gamida Cell initiated with an Outperform at Oppenheimer
Oppenheimer analyst Mark Breidenbach started Gamida Cell with an Outperform rating and $15 price target. The analyst sees Gamida's proprietary cell expansion technology as a "versatile approach for improving the performance of cell-based products." He believes the company's lead product, NiCord, could provide a safe and effective source of stem cells for transplant patients who lack compatible donors.
11/21/18
11/21/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. BeiGene (BGNE) initiated with an Overweight at JPMorgan. 2. Gamida Cell (GMDA) initiated with an Outperform at BMO Capital and Oppenheimer. 3. Marker Therapeutics (MRKR) initiated with a Buy at Nomura Instinet. 4. Arco Platform (ARCE) initiated with a Buy at UBS. 5. nVent Electric (NVT) initiated with a Hold at Vertical Research. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/26/18
NEED
11/26/18
INITIATION
Target $23
NEED
Buy
Gamida Cell initiated with a Buy at Needham
Needham analyst Chad Messer initiated Gamida Cell with a Buy rating and a price target of $23. The analyst notes that nearly half of the U.S. patients who are eligible for stem cell transplants never receive one because they cannot find a suitable bone marrow donor. Messer states that Gamida Cell's NiCord system addresses the "shortcomings of cord blood transplantation by using its proprietary technology to maintain cell 'stemness' during expansion in culture". The analyst is therefore positive on the company's "promise of greatly increasing the number of transplant-eligible patients who can find a potentially lifesaving donor match."
11/26/18
11/26/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Nvidia (NVDA) initiated with an Outperform at Credit Suisse. 2. Orchard Therapeutics (ORTX) initiated with an Outperform at Wedbush and Cowen, an Overweight at JPMorgan, and a Neutral at Goldman Sachs. 3. Twist Bioscience (TWST) initiated with an Outperform at Cowen and Baird as well as a Neutral at JPMorgan. 4. Axonics (AXNX) initiated with a Buy at BofA/Merrill and SunTrust, an Outperform at Wells Fargo, and an Overweight at Morgan Stanley. 5. Gamida Cell (GMDA) initiated with a Buy at Needham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

21:23
07/22/19
07/22
21:23
07/22/19
21:23
Downgrade
Stifel downgrades Viveve to Hold after trial miss, cuts target to $1 »

Stifel analyst Jonathan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

21:15
07/22/19
07/22
21:15
07/22/19
21:15
Hot Stocks
Viveve CMRF technology trial did not demonstrate improvement in SUI »

Earlier this evening,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

21:12
07/22/19
07/22
21:12
07/22/19
21:12
Downgrade
Viveve rating change  »

Viveve downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KO

Coca-Cola

$51.25

-0.15 (-0.29%)

, UTX

United Technologies

$132.94

0.57 (0.43%)

20:25
07/22/19
07/22
20:25
07/22/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

KO

Coca-Cola

$51.25

-0.15 (-0.29%)

UTX

United Technologies

$132.94

0.57 (0.43%)

LMT

Lockheed Martin

$357.57

0.675 (0.19%)

KMB

Kimberly-Clark

$134.40

-1.31 (-0.97%)

BIIB

Biogen

$232.46

1.26 (0.54%)

SHW

Sherwin-Williams

$454.62

-1.9 (-0.42%)

TRV

Travelers

$149.95

-0.22 (-0.15%)

PCAR

Paccar

$69.17

-0.16 (-0.23%)

CNC

Centene

$52.19

-0.46 (-0.87%)

SWK

Stanley Black & Decker

$141.45

-2.01 (-1.40%)

FITB

Fifth Third

$27.84

-0.11 (-0.39%)

KEY

KeyCorp

$17.37

-0.08 (-0.46%)

TRU

TransUnion

$74.91

-0.14 (-0.19%)

HAS

Hasbro

$108.54

0.85 (0.79%)

DGX

Quest Diagnostics

$98.07

-1.175 (-1.18%)

LW

Lamb Weston

$67.58

-0.98 (-1.43%)

JBLU

JetBlue

$18.96

0.05 (0.26%)

HOG

Harley-Davidson

$34.25

-0.62 (-1.78%)

MDSO

Medidata

$90.93

0.2 (0.22%)

GPK

Graphic Packaging

$14.27

0.025 (0.18%)

AN

AutoNation

$42.01

-0.045 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 01

    Aug

  • 01

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 12

    Aug

  • 29

    Aug

  • 09

    Sep

  • 19

    Sep

  • 13

    Nov

ACAD

Acadia

$25.97

0.28 (1.09%)

20:21
07/22/19
07/22
20:21
07/22/19
20:21
Recommendations
Acadia analyst commentary at Piper Jaffray »

Acadia's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 20

    Aug

EFII

Electronics for Imaging

$36.97

(0.00%)

20:12
07/22/19
07/22
20:12
07/22/19
20:12
Hot Stocks
Breaking Hot Stocks news story on Electronics for Imaging »

Electronics for Imaging…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZION

Zions Bancorp

$45.16

-0.95 (-2.06%)

20:04
07/22/19
07/22
20:04
07/22/19
20:04
Downgrade
Zions Bancorp rating change at Wells Fargo »

Zions Bancorp downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

CADE

Cadence Bancorp

$15.86

-3.75 (-19.12%)

20:03
07/22/19
07/22
20:03
07/22/19
20:03
Downgrade
Cadence Bancorp rating change  »

Cadence Bancorp cut to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 06

    Aug

  • 26

    Aug

  • 23

    Sep

OISHY

Oil Search

$0.00

(0.00%)

19:38
07/22/19
07/22
19:38
07/22/19
19:38
Upgrade
Oil Search rating change at Morgan Stanley »

Oil Search upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$75.93

0.9 (1.20%)

, INTC

Intel

$51.36

1.1 (2.19%)

19:11
07/22/19
07/22
19:11
07/22/19
19:11
Periodicals
Trump to grant timely licensing decisions for Huawei sales, WSJ reports »

U.S. President Donald…

QCOM

Qualcomm

$75.93

0.9 (1.20%)

INTC

Intel

$51.36

1.1 (2.19%)

GOOG

Alphabet

$1,138.09

8.09 (0.72%)

GOOGL

Alphabet Class A

$1,139.52

7.85 (0.69%)

MU

Micron

$47.21

1.7 (3.74%)

WDC

Western Digital

$55.32

2.87 (5.47%)

CSCO

Cisco

$57.72

0.34 (0.59%)

AVGO

Broadcom

$296.11

6.06 (2.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 31

    Jul

  • 31

    Jul

  • 03

    Aug

  • 08

    Aug

  • 14

    Aug

  • 27

    Oct

LPL

LG Display

$7.45

0.275 (3.83%)

18:51
07/22/19
07/22
18:51
07/22/19
18:51
Periodicals
Breaking Periodicals news story on LG Display »

LG Display to invest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

F

Ford

$10.02

-0.03 (-0.30%)

18:51
07/22/19
07/22
18:51
07/22/19
18:51
Periodicals
Ford to spend $50M to upgrade Chicago plant for SUVs, Reuters reports »

Ford intends to invest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 23

    Oct

BRO

Brown & Brown

$34.64

-0.11 (-0.32%)

, SNAP

Snap

$14.14

0.12 (0.86%)

18:48
07/22/19
07/22
18:48
07/22/19
18:48
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Brown…

BRO

Brown & Brown

$34.64

-0.11 (-0.32%)

SNAP

Snap

$14.14

0.12 (0.86%)

INTC

Intel

$51.36

1.1 (2.19%)

QCOM

Qualcomm

$75.93

0.9 (1.20%)

STLD

Steel Dynamics

$31.55

0.09 (0.29%)

ZION

Zions Bancorp

$45.16

-0.95 (-2.06%)

CDNS

Cadence Design

$72.68

-0.21 (-0.29%)

SNPS

Synopsys

$135.42

0.41 (0.30%)

WHR

Whirlpool

$148.30

0.085 (0.06%)

AMTD

TD Ameritrade

$52.41

0.82 (1.59%)

ACAD

Acadia

$25.97

0.28 (1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 22

    Jul

  • 22

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 25

    Jul

  • 31

    Jul

  • 31

    Jul

  • 03

    Aug

  • 06

    Aug

  • 20

    Aug

  • 21

    Aug

  • 26

    Sep

  • 27

    Sep

SNAP

Snap

$14.14

0.12 (0.86%)

18:35
07/22/19
07/22
18:35
07/22/19
18:35
Upgrade
Snap rating change at Stifel »

Snap upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 03

    Aug

SMBC

Southern Missouri Bancorp

$31.95

-0.3 (-0.93%)

18:33
07/22/19
07/22
18:33
07/22/19
18:33
Earnings
Southern Missouri Bancorp sees Q4 EPS 81c, consensus 77c »

Southern Missouri…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

SSRM

SSR Mining

$15.80

-0.06 (-0.38%)

18:32
07/22/19
07/22
18:32
07/22/19
18:32
Hot Stocks
SSR Mining to acquire remaining 25% interest in Puna Operations »

SSR Mining announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

SNAP

Snap

$14.14

0.12 (0.86%)

18:23
07/22/19
07/22
18:23
07/22/19
18:23
Upgrade
Snap rating change at Stifel »

Snap upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 03

    Aug

HD

Home Depot

$211.23

-1.79 (-0.84%)

18:22
07/22/19
07/22
18:22
07/22/19
18:22
Hot Stocks
Home Depot CFO: The company is in great hands »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

AN

AutoNation

$42.01

-0.045 (-0.11%)

18:21
07/22/19
07/22
18:21
07/22/19
18:21
Hot Stocks
Breaking Hot Stocks news story on AutoNation »

AutoNation down 2.6%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 13

    Nov

AN

AutoNation

$42.01

-0.045 (-0.11%)

18:17
07/22/19
07/22
18:17
07/22/19
18:17
Earnings
AutoNation reports Q2 cont ops EPS $1.12, consensus $1.06 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 13

    Nov

CR

Crane

$86.50

0.99 (1.16%)

18:15
07/22/19
07/22
18:15
07/22/19
18:15
Earnings
Crane backs FY19 adjusted EPS view of $6.25-$6.45, consensus $6.41 »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 09

    Sep

  • 09

    Sep

CR

Crane

$86.50

0.99 (1.16%)

18:14
07/22/19
07/22
18:14
07/22/19
18:14
Earnings
Crane Co. reports Q2 EPS ex-items $1.58, consensus $1.56 »

Reports Q2 revenue $842M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 09

    Sep

  • 09

    Sep

AN

AutoNation

$42.01

-0.045 (-0.11%)

, GOOG

Alphabet

$1,138.09

8.09 (0.72%)

18:11
07/22/19
07/22
18:11
07/22/19
18:11
Hot Stocks
AutoNation names Cheryl Miller CEO »

AutoNation (AN) announced…

AN

AutoNation

$42.01

-0.045 (-0.11%)

GOOG

Alphabet

$1,138.09

8.09 (0.72%)

GOOGL

Alphabet Class A

$1,139.52

7.85 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 25

    Jul

  • 25

    Jul

  • 03

    Aug

  • 08

    Aug

  • 27

    Oct

  • 13

    Nov

STLD

Steel Dynamics

$31.55

0.09 (0.29%)

18:04
07/22/19
07/22
18:04
07/22/19
18:04
Hot Stocks
Steel Dynamics reports Q2 operating income $295M, down 6% from Q1 »

Q2 average external…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 06

    Aug

FBMS

First Bancshares

$29.74

-0.105 (-0.35%)

18:03
07/22/19
07/22
18:03
07/22/19
18:03
Hot Stocks
First Bancshares announces agreement to acquires First Florida Bancorp »

The First Bancshares,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.